INSY
Insys Therapeutics, Inc.
INSY
INSY
Delisted
INSY was delisted on the 18th of June, 2019.
113 hedge funds and large institutions have $42.5M invested in Insys Therapeutics, Inc. in 2018 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 22 increasing their positions, 24 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
69% less capital invested
Capital invested by funds: $136M → $42.5M (-$93M)
Holders
113
Holding in Top 10
–
Calls
$253K
Puts
$551K
Top Buyers
| 1 | +$5.08M | |
| 2 | +$1.1M | |
| 3 | +$998K | |
| 4 |
Millennium Management
New York
|
+$898K |
| 5 |
JC
JBF Capital
Aspen,
Colorado
|
+$350K |
Top Sellers
| 1 | -$30.5M | |
| 2 | -$1.92M | |
| 3 | -$621K | |
| 4 |
CWM
Cornerstone Wealth Management
St. Peters,
Missouri
|
-$400K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$324K |